Patent classifications
A61M2230/60
System for enhancing sleep recovery and promoting weight loss
The present invention provides systems, methods, and articles for stress reduction and sleep promotion. A stress reduction and sleep promotion system includes at least one remote device, at least one body sensor, and at least one remote server. In other embodiments, the stress reduction and sleep promotion system includes machine learning.
INTELLIGENT CONTROL APPARATUS AND CONTROL METHOD THEREFOR, AND INTELLIGENT WEARABLE DEVICE
This application provides an intelligent control apparatus, including: a control circuit and a detection and heating circuit. The detection and heating circuit includes a detection and heating material. When the detection heating material works in a detection mode, the detection and heating circuit obtains a bioelectric signal of a user by using the detection and heating material. The control circuit instructs, according to the bioelectric signal, the detection heating circuit to switch a working mode of the detection and heating material to a heating mode; and instructs the detection and heating circuit to determine heating duration and/or a heating temperature of the detecting and heating material. The apparatus may be used in the field of artificial intelligence. Through control of the control circuit, the detection heating material can have both detection and heating functions. Intelligent perception of a state of the user is implemented by detecting of the bioelectric signal.
Apparatus for Prevention of Apnea
The present invention relates to an automated stimulation device for inducing a tactile inter-stimulus onset asynchrony (ISOA) effect in a subject suffering from apnea, bradycardia and/or hypoxia, the device comprising at least two actuators configured for contacting a body portion of the subject, and interspaced for producing an apparent tactile movement in the subject upon sequential induction of actuation, wherein the duration of the actuations and the overlap in actuation time between the at least two actuators is controlled to attain an inter stimulus onset asynchrony (ISOA).
Apparatus for Prevention of Apnea
The present invention relates to an automated stimulation device for inducing a tactile inter-stimulus onset asynchrony (ISOA) effect in a subject suffering from apnea, bradycardia and/or hypoxia, the device comprising at least two actuators configured for contacting a body portion of the subject, and interspaced for producing an apparent tactile movement in the subject upon sequential induction of actuation, wherein the duration of the actuations and the overlap in actuation time between the at least two actuators is controlled to attain an inter stimulus onset asynchrony (ISOA).
METHOD FOR DELIVERING A DIGITAL THERAPY RESPONSIVE TO A USER'S PHYSIOLOGICAL STATE AT A SENSORY IMMERSION VESSEL
One variation of a method for delivering a digital medicine experience to a user includes: loading the digital medicine experience at a sensory immersion vessel; calculating a target value of a bioindicator of the physiological state of the user, the target value of the bioindicator corresponding to a target physiological state of the user; at an initial time, rendering sensory representations of a set of elements in a multi-sensory virtual environment within the sensory immersion vessel at an initial progression rate; at a time during the digital medicine experience, succeeding the initial time, measuring a value of the bioindicator; calculating a progression rate through the digital medicine experience based on a difference between the value of the bioindicator and the target value of the bioindicator; and at a second time succeeding the time, rendering sensory representations of the set of elements in the multi-sensory virtual environment at the progression rate.
METHOD FOR DELIVERING A DIGITAL THERAPY RESPONSIVE TO A USER'S PHYSIOLOGICAL STATE AT A SENSORY IMMERSION VESSEL
One variation of a method for delivering a digital medicine experience to a user includes: loading the digital medicine experience at a sensory immersion vessel; calculating a target value of a bioindicator of the physiological state of the user, the target value of the bioindicator corresponding to a target physiological state of the user; at an initial time, rendering sensory representations of a set of elements in a multi-sensory virtual environment within the sensory immersion vessel at an initial progression rate; at a time during the digital medicine experience, succeeding the initial time, measuring a value of the bioindicator; calculating a progression rate through the digital medicine experience based on a difference between the value of the bioindicator and the target value of the bioindicator; and at a second time succeeding the time, rendering sensory representations of the set of elements in the multi-sensory virtual environment at the progression rate.
NON-PHARMACEUTICAL SYSTEMS AND METHODS OF TREATING THE SYMPTOMS OF FIBROMYALGIA
Non-pharmaceutical systems and methods of treating the symptoms of fibromyalgia are described. The method includes administering a therapeutically effective amount of a sensory stimulus to a person, wherein the sensory stimulus includes one or more visual stimuli and one or more auditory stimuli.
NON-PHARMACEUTICAL SYSTEMS AND METHODS OF TREATING THE SYMPTOMS OF FIBROMYALGIA
Non-pharmaceutical systems and methods of treating the symptoms of fibromyalgia are described. The method includes administering a therapeutically effective amount of a sensory stimulus to a person, wherein the sensory stimulus includes one or more visual stimuli and one or more auditory stimuli.
SYSTEMS AND METHODS FOR DETECTING MOUTH LEAK
The present disclosure relates to a method for determining a mouth leak status associated with a user of a respiratory device is disclosed. Airflow data associated with the user of the respiratory device is received. The respiratory device is configured to supply pressurized air to an airway of the user during a therapy session. The airflow data includes pressure data. The airflow data associated with the user is analyzed. Based at least in part on the analysis, the mouth leak status associated with the user is determined. The mouth leak status is indicative of whether or not air is leaking from a mouth of the user.
VENTILATION APPARATUS
A ventilation apparatus has a breathing gas delivery system for delivering breathing gas to a user of the apparatus as ventilation therapy, with a controllable pressure and flow. The breathing pressure and flow are monitored to derive a respiration variability. A state of relaxation of the user is derived during provision of breathing assistance based on at least the respiration variability. Settings of the ventilation apparatus are then adapted dependence on the estimated state of relaxation for assisting the user in habituating to the breathing assistance, and hence habituating to breathing therapy.